Replies to post #168582 on Biotech Values

[DewDiligence]

MYGN acquires private company for $270M in cash:

http://finance.yahoo.com/news/myriad-genetics-acquire-crescendo-bioscience-210300836.html

Myriad Genetics, Inc. (MYGN) announced today that it has entered into a definitive agreement to acquire Crescendo Bioscience, Inc., a global leader in autoimmune diagnostics, for $270 million in cash…

… Crescendo was founded in July 2002 and is a leading molecular diagnostic laboratory in the area of inflammatory and autoimmune diseases. Their core product, Vectra(R) DA, is a quantitative, protein-based test to routinely assess rheumatoid arthritis disease activity and provide rheumatologists with expanded clinical insights to more effectively treat their patients.